Medinotec Inc.
Medinotec Inc. engages in the research and development, production, and sale of medical devices for the treatment of vascular and airway diseases in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, … Read more
Market Cap & Net Worth: Medinotec Inc. (MDNC)
Medinotec Inc. (PINK:MDNC) has a market capitalization of $58.78 Million ($58.78 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #28964 globally and #9619 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medinotec Inc.'s stock price $5.00 by its total outstanding shares 11755548 (11.76 Million).
Medinotec Inc. Market Cap History: 2023 to 2025
Medinotec Inc.'s market capitalization history from 2023 to 2025. Data shows growth from $58.78 Million to $58.78 Million (0.00% CAGR).
Medinotec Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medinotec Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.45x
Medinotec Inc.'s market cap is 6.45 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
27.22x
Medinotec Inc.'s market cap is 27.22 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $58.78 Million | $999.58K | -$352.74K | 58.80x | N/A |
| 2024 | $58.78 Million | $5.02 Million | -$404.69K | 11.71x | N/A |
| 2025 | $58.78 Million | $9.11 Million | $2.16 Million | 6.45x | 27.22x |
Competitor Companies of MDNC by Market Capitalization
Companies near Medinotec Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Medinotec Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Medinotec Inc. Historical Marketcap From 2023 to 2025
Between 2023 and today, Medinotec Inc.'s market cap moved from $58.78 Million to $ 58.78 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $58.78 Million | 0.00% |
| 2024 | $58.78 Million | 0.00% |
| 2023 | $58.78 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Medinotec Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $58.78 Million USD |
| MoneyControl | $58.78 Million USD |
| MarketWatch | $58.78 Million USD |
| marketcap.company | $58.78 Million USD |
| Reuters | $58.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.